IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Dec 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-12-01

Reporting Person: COLLINS Asha (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-01	Deferred Stock Unit	$	A	109	Acquired		Common Stock (109)	Direct
2020-12-01	Non-Qualified Stock Option (right-to-buy)	$467.86	A	358	Acquired	2030-11-30	Common Stock (358)	Direct

Footnotes

F1: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from her election to the IDEXX Laboratories, Inc. Board of Directors on November 11, 2020 until the 2021 annual meeting of stockholders.

F2: Each deferred stock unit ('DSU') represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2021 annual meeting of stockholders or May 6, 2021, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 6, 2021.

F4: Not applicable.